1. Home
  2. BBAI vs PGEN Comparison

BBAI vs PGEN Comparison

Compare BBAI & PGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo BigBear.ai Inc.

BBAI

BigBear.ai Inc.

HOLD

Current Price

$2.77

Market Cap

1.4B

Sector

Technology

ML Signal

HOLD

Logo Precigen Inc.

PGEN

Precigen Inc.

HOLD

Current Price

$6.12

Market Cap

1.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BBAI
PGEN
Founded
2020
1998
Country
United States
United States
Employees
579
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.4B
1.6B
IPO Year
N/A
2013

Fundamental Metrics

Financial Performance
Metric
BBAI
PGEN
Price
$2.77
$6.12
Analyst Decision
Buy
Buy
Analyst Count
2
5
Target Price
$5.50
$8.33
AVG Volume (30 Days)
23.4M
3.7M
Earning Date
05-05-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$230,981,000.00
Revenue This Year
$13.89
$1,115.92
Revenue Next Year
$11.71
$81.04
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.59
$1.70
52 Week High
$9.39
$6.04

Technical Indicators

Market Signals
Indicator
BBAI
PGEN
Relative Strength Index (RSI) 35.34 65.51
Support Level N/A $3.96
Resistance Level $4.44 $6.04
Average True Range (ATR) 0.18 0.31
MACD 0.01 0.04
Stochastic Oscillator 19.57 79.59

Price Performance

Historical Comparison
BBAI
PGEN

About BBAI BigBear.ai Inc.

BigBear.ai Holdings Inc is a provider of mission-ready artificial intelligence (AI) technology originally founded to serve defense and national security mission customers. The Company provides Edge AI-powered decision intelligence solutions, including artificial intelligence and machine learning, generative AI, data science, computer vision, biometrics, cyber, cloud solutions, and systems integration. Customers rely on its predictive analytics capabilities in mission-based operating environments. Its solutions are organized into five markets, including Supply Chain & Logistics Solutions, Cybersecurity Solutions, Autonomous Systems Solutions, Digital Identity Services, and the Ask Sage Platform.

About PGEN Precigen Inc.

Precigen Inc is a commercial-stage biopharmaceutical company focused on developing precision medicines to improve the lives of patients, targeting immuno-oncology, autoimmune disorders, and infectious diseases using its proprietary and complementary technology platforms. These platforms support the development of gene programs, delivery through viral, non-viral, and microbe-based approaches, and control of gene expression for safety and efficacy. Its key platforms include AdenoVerse immunotherapy and UltraCAR-T, supported by the UltraPorator device for rapid and cost-effective manufacturing. Its clinical pipeline includes PRGN-2009, PRGN-3005, PRGN-3006, and PRGN-3007. Its reportable segments are Biopharmaceuticals and Exemplar.

Share on Social Networks: